Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
By Rishika Sadam HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world’s most populous country grappling with increasing rates of obesity and diabetes. U.S.-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with investor interest also boosting the drugmakers’ valuations. Mounjaro, a once-weekly injection approved by India’s drug regulator, is … Read more…